future clinical trials must evaluate whether aligning treatments with the body's internal clock can enhance patient outcomes. "This discovery opens up new avenues for treating heart attacks by ...

That's causing unnecessary and avoidable heart attacks and deaths – and also places unnecessary costs on healthcare systems. Our study shows the way forward; care pathways must now change for ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

That’s causing unnecessary and avoidable heart attacks and deaths – and also places unnecessary costs on healthcare systems. Our study shows the way forward; care pathways must now change for ...

"If you have a heart attack ... AREG pathway with drugs, researchers found they could provide significant protection to the heart, especially when treatments were timed to align with the body's ...

That’s causing unnecessary and avoidable heart attacks and deaths – and also places unnecessary costs on healthcare systems. “Our study shows the way forward; care pathways must now ... models to ...

That’s causing unnecessary and avoidable heart attacks and deaths – and also places unnecessary costs on healthcare systems. "Our study shows the way forward; care pathways must now ... models to ...

Heart attacks often present with subtle symptoms beyond the dramatic chest-clutching portrayal. Unusual fatigue, discomfort in the neck, jaw, or back, nausea, and shortness of breath can be ...

The following is a summary of "Safety and Effectiveness of the High-Sensitivity HEART Pathway Safely Across Age Groups in ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

When inflamed plaques grow large, they become prone to rupture, which can cause heart attack. Evolocumab is in a class of drugs called PCSK9 inhibitors that can dramatically reduce cholesterol.